Selecta Biosciences Initiates Phase 1 Clinical Study of SEL-068, a First-in ... MarketWatch (press release) Examples for applications include autoimmune diseases, allergies and transplant rejection. Selecta's pipeline currently contains a vaccine for smoking cessation and relapse prevention, a vaccine for Type 1 Diabetes, vaccines for several infectious ... |
